EzFill (NASDAQ:EZFL) stock is taking a beating on Tuesday despite the company releasing positive data from the second quarter of 2023.
According to a press release from the company, its gallons delivered during the quarter jumped a massive 100% year-over-year (YOY) to 1.58 million gallons. The company also noted that this marks a 20% increase compared to gallons delivered in Q1 2023.
EzFill notes that this major increase in gallons delivered is due to a couple of reasons. Among them is adding 53 new fleet accounts since the start of the year. The company also expanded its residential and marine-focused marketing and is starting to see new orders in those markets as a result.
Yehuda Levy, co-founder and interim CEO of EzFill, said the following about the news:
“The fleet business continues its consistent growth in our locations throughout Florida. Additionally, on the residential and marine side we continue to see the results of our targeted marketing campaigns. Additionally, we recently launched a condominium and homeowners association offering and we believe that signing on condominiums and HOAs will result in additional growth in our residential vertical.”
EZFL Stock Movement on Tuesday
EZFL stock isn’t seeing much trading activity today despite its data for Q2 2023. What is worth noting, however, is that the company saw a major drop in price by about 45% in pre-market trading today. However, the stock has mostly recovered from that drop, now only down 4.5% shortly before markets open on Tuesday.
Investors seeking out even more of the most recent stock market news for Tuesday will want to stick around!
We’ve got all of the latest stock market coverage traders need to know about today! A few examples include why shares of Better Therapeutics (NASDAQ:BTTX) and CytoMed Therapeutics (NASDAQ:GDTC) stock are up, as well as the biggest pre-market stock movers this morning. You can find out all about these matters at the following links!
More Tuesday Stock Market News
- Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
- Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
